Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve cardiovascular outcomes in patients with type 2 diabetes mellitus (T2D). The comparative efficacy of individual SGLT2i remains unclear. We searched PubMed, www.clinicaltrials.gov and the Cochrane Central Register of Controlled Trials for ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Täger, Tobias, Atar, Dan, Agewall, Stefan, Katus, Hugo A., Grundtvig, Morten, Cleland, John G. F., Clark, Andrew L., Fröhlich, Hanna, Frankenstein, Lutz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510986/
https://www.ncbi.nlm.nih.gov/pubmed/32314085
http://dx.doi.org/10.1007/s10741-020-09954-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510986/
https://www.ncbi.nlm.nih.gov/pubmed/32314085
http://dx.doi.org/10.1007/s10741-020-09954-8

Ejemplares similares